CIK 0001534120 · Non-accelerated filer<br>Smaller reporting company
Avalo Therapeutics, Inc.
Sign in to watch- Ticker
- AVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450705648
- Phone
- 410-522-8707
- Business address
- 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
- Former names
- Cerecor Inc.
- 4 Shares withheld for taxes Chief Financial Officer gave up 138 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 1,084 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Medical Officer sold 679 shares at $16.00 ($10,864)
- 4 Grant or award Chief Strategy Officer acquired 34,200 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 39,900 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 24,300 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 43,500 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 100,200 shares (grant or award)
- 4 Planned sale Chief Medical Officer sold 3,000 shares at $18.76 ($56,280)
- 4 Planned sale Chief Financial Officer sold 18,606 shares at $24.12 ($448,818)
- 4 Planned sale Chief Legal Officer sold 75,063 shares at an average $20.17 ($1,513,673)
- 4 Planned sale Chief Financial Officer sold 47,000 shares at an average $20.19 ($948,722)
- 4 Planned sale Chief Medical Officer sold 108,234 shares at an average $20.61 ($2,230,367)
- 4 Planned sale Director sold 3,167 shares at $22.88 ($72,461)
Page 2 of 28 · 552 filings